Sun Pharma's U.S. unit donates hydroxychloroquine sulfate tablets in fight against coronavirus
Published
A subsidiary of India's Sun Pharmaceutical Industries Ltd said on Friday it had donated 2.5 million hydroxychloroquine sulfate tablets in the United States as a potential treatment for coronavirus.
Full Article